Applicability of ribosome engineering to vitamin B12 production by Propionibacterium shermanii

Bioscience, Biotechnology and Biochemistry

Volumn 81, Issue 8, 2017, Pages 1636-1641

  Tanaka, Yukinori ^a   Kasahara, Ken ^b   Izawa, Masumi ^a   Ochi, Kozo ^a  

^a HIROSHIMA INSTITUTE OF TECHNOLOGY   (Japan)

^b Biotechnology Research Center   (Japan)

Author keywords

Drug resistance mutation; Propionibacterium shermanii; Ribosome engineering; Vitamin B12

Indexed keywords

MACROMOLECULES; METABOLISM; METABOLITES; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TRANSCRIPTION;

DRUG RESISTANCE; PRIMARY METABOLITE; RIBOSOME ENGINEERING; SECONDARY METABOLISM; SECONDARY METABOLITES; SHERMANII; TRANSCRIPTIONAL LEVELS; VITAMIN B-12;

METABOLIC ENGINEERING;

BACTERIAL PROTEIN; CYANOCOBALAMIN; DNA DIRECTED RNA POLYMERASE; ERYTHROMYCIN; GENTAMICIN; RIFAMPICIN; TRANSFERASE;

ANTIBIOTIC RESISTANCE; BIOSYNTHESIS; DNA SEQUENCE; DRUG EFFECTS; FERMENTATION; GENE EXPRESSION; GENETIC ENGINEERING; GENETICS; METABOLISM; MUTATION; PROPIONIBACTERIUM; RIBOSOME;

ALKYL AND ARYL TRANSFERASES; BACTERIAL PROTEINS; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FERMENTATION; GENE EXPRESSION; GENETIC ENGINEERING; GENTAMICINS; MUTATION; PROPIONIBACTERIUM; RIBOSOMES; RIFAMPIN; SEQUENCE ANALYSIS, DNA; VITAMIN B 12;

EID: 85024874491     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1080/09168451.2017.1329619     Document Type: Article

References (28)

1. Ochi K. Insights into microbial cryptic gene activation and strain improvement: principle, application and technical aspects. J Antibiot. 2017;70:25–40.
2. Ochi K, Tanaka Y, Tojo S. Activating the expression of bacterial cryptic genes by rpoB mutations in RNA polymerase or by rare earth elements. J Ind Microbiol Biotechnol. 2014;41:403–414.
3. Ochi K, Hosaka T. New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters. Appl Microbiol Biotechnol. 2013;97:87–98.
4. Hosaka T, Ohnishi-Kameyama M, Muramatsu H, et al. Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12. Nat Biotechnol. 2009;27:462–464.
5. Tanaka Y, Kasahara K, Hirose Y, et al. Activation and products of the cryptic secondary metabolite biosynthetic gene clusters by rifampin resistance (rpoB) mutations in actinomycetes. J Bacteriol. 2013;195:2959–2970.
6. Burgess CM, Smid EJ, van Sinderen D. Bacterial vitamin B2, B11 and B12 overproduction: an overview. Int J Food Microbiol. 2009;133:1–7.
7. Martens J-H, Barg H, Warren MJ, et al. Microbial production of vitamin B12. Appl Microbiol Biotechnol. 2002;58:275–285.
8. Murooka Y, Piao Y, Kiatpapan P, et al. Production of tetrapyr-role compounds and vitamin B12 using genetically engineering of Propionibacterium freudenreichii: An overview. Lait. 2005;85:9–22.
9. Thierry A, Deutsch SM, Falentin H, et al. New insights into physiology and metabolism of Propionibacterium freudenreichii. Int J Food Microbiol. 2011;149:19–27.
10. Seidametova EA, Shakirzyanova MP, Ruzieva DM. Isolation of cobalt-resistant strains of propionic acid bacteria, potent producers of vitamin B12. Appl Biochem Microbiol. 2004;40:560–562.
11. Moore SJ, Mayer MJ, Biedendieck R, et al. Towards a cell factory for vitamin B12 production in Bacillus megaterium: bypassing of the cobalamin riboswitch control elements. New Biotechnol. 2014;31:553–561.
12. Warren MJ, Raux E, Schubert HL, et al. The biosynthesis of adenosylcobalamin (vitamin B12). Nat Prod Rep. 2002;19: 390–v.
13. Raux E, Schubert HL, Warren MJ. Biosynthesis of cobalamin (vitamin B12): a bacterial conundrum. Cell Mol Life Sci. 2000;57:1880–1893.
14. Kang Z, Zhang J, Zhou J, et al. Recent advances in microbial production of δ-aminolevulinic acid and vitamin B12. Biotechnol Adv. 2012;30:1533–1542.
15. Survase SA, Bajaj IB, Singhal RS. Biotechnological production of vitamins. Food Technol Biotechnol. 2006;44:381–396.
16. Zhang Y, Liu J-Z, Huang J-S, et al. Genome shuffling of Propionibacterium shermanii for improving vitamin B12 production and comparative proteome analysis. J Biotechnol. 2010;148:139–143.
17. Piao Y, Yamashita M, Kawaraichi N, et al. Production of vitamin B12 in genetically engineered Propionibacterium freudenreichii. J Biosci Bioeng. 2004;98:167–173.
18. Li Y. Production of vitamin B12 in recombinant Escherichia coli: an important step for heterologous production of structurally complex small molecules. Biotechnol J. 2014;9: 1478–1479.
19. Shiwa Y, Fukushima-Tanaka S, Kasahara K, et al. Whole-genome profiling of a novel mutagenesis technique using proofreading-deficient DNA polymerase σ. Int J Evol Biol. 2012;2012:8,860797.
20. Yano S. Breeding of the industrial yeast strains using the disparity mutagenesis (in Japanese). Seibutsu Kogaku Kaishi. 2011;89:524–526.
21. Falentin H, Deutsch S-M, Jan G, et al. The complete genome of Propionibacterium freudenreichii CIRM-BIA1, a hardy acti-nobacterium with food and probiotic applications. PLoS One. 2010;5:e11748.
22. Tanaka Y, Hosaka T, Ochi K. Rare earth elements activate the secondary metabolite-biosynthetic gene clusters in Streptomyces coelicolor A3(2). J Antibiot. 2010;63:477–481.
23. Gao X, Zhao H, Zhang G, et al. Genome shuffling of Clostridium acetobutylicum CICC 8012 for improved production of acetone–butanol–ethanol (ABE). Curr Microbiol. 2012;65:128–132.
24. Chen L, Shang G, Yuan W, et al. Screening of Clostridium strains through ribosome engineering for improved butanol production (in Chinese). Chin J Biotech. 2012;28:1048–1058.
25. Suzuki T, Seta K, Nishikawa C, et al. Improved ethanol tolerance and ethanol production from glycerol in a streptomycin-resistant Klebsiella variicola mutant obtained by ribosome engineering. Bioresour Technol. 2015;176:156–162.
26. Tala A, Wang G, Zemanova M, et al. Activation of dormant bacterial genes by Nonomuraea sp. strain ATCC 39727 mutant-type RNA polymerase. J Bacteriol. 2009;191:805–814.
27. Alifano P, Palumbo C, Pasanisi D, et al. Rifampicin-resistance, rpoB polymorphism and polymerase genetic engineering. J Biotechnol. 2015;202:60–77.
28. Imai Y, Fujiwara T, Ochi K, et al. Development of the ability to produce secondary metabolites in Streptomyces through the acquisition of erythromycin resistance. J Antibiot. 2012;65:323–326.